Remote Evaluation and Surveillance of Patients With Interstitial Lung Disease: Transforming ILD Care Delivery With Remote Monitoring

Recruiting

Who can join

Ages 18 and older · All sexes

Full eligibility criteria

Inclusion Criteria:

* age 18 or older
* English or Spanish speaking
* have a UCSF diagnosis of one of the major ILD subtypes seen in the ILD Clinic (Idiopathic Pulmonary Fibrosis, Chronic Hypersensitivity Pneumonitis, Connective-tissue disease related ILD, Sarcoidosis, Familial Fibrosis). Languages are limited to those for which both device instructional materials and user support are available (written and video). The ILD diagnosis will be based on multidisciplinary conference review, which is the diagnostic gold standard. We have restricted the ILD subtypes to those for which there is efficacy data for RPM or comparable clinical trajectories, and subtypes that account for \>10% of the ILD diagnoses seen at UCSF.

Exclusion Criteria:

* Patients who are unable provide informed consent for any reason or are acutely ill.

About the study

The purpose of this interventional study is to identify which combination of remote monitoring devices (e.g. home spirometry, pulse oximetry, scale, ePROs) is the most feasible (as defined by adherence, retention, and data completeness) and acceptable when used for the detection of clinically significant Interstitial Lung Disease events.

What is being tested

Spirometer (device)
Oximeter (device)
Scale (device)
ePROs (electronic patient reported outcomes) (other)

Sponsor: University of California, San Francisco · Participants: 200 · Started: Oct 1, 2026

Contact the study team

Erica D Farrand, MD · Phone: 415-476-8067
Yeji Lee · Phone: 415-353-9744

Official record on ClinicalTrials.gov — NCT07673237

Locations in the U.S.

California

University of California, San Francisco, San Francisco

Conditions

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.